CONDUIT PHARMACEUTICALS INC. Annual Net Cash Provided by (Used in) Financing Activities in USD from 2022 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Conduit Pharmaceuticals Inc. annual/quarterly Net Cash Provided by (Used in) Financing Activities history and growth rate from 2022 to 2023.
  • Conduit Pharmaceuticals Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2023 was $2.22M, a 98.4% decline year-over-year.
  • Conduit Pharmaceuticals Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $10.9M, a 346% increase from 2022.
Net Cash Provided by (Used in) Financing Activities, Annual (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $10.9M +$8.48M +346% Jan 1, 2023 Dec 31, 2023 10-K 2024-04-16
2022 $2.45M Jan 1, 2022 Dec 31, 2022 10-K 2024-04-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.